Yes, hydrochlorothiazide (HCTZ) increases serum uric acid levels.
Hydrochlorothiazide definitively increases serum uric acid in many patients receiving this medication, as confirmed by both FDA labeling and major hypertension guidelines 1, 2. This is a well-established pharmacologic effect that occurs through decreased renal excretion of uric acid 2.
Mechanism and Clinical Significance
HCTZ decreases the excretion of uric acid through its action on renal tubular transport 2. The drug blocks sodium and chloride reabsorption in the distal tubule, and this mechanism interferes with uric acid excretion, leading to elevated serum levels.
Magnitude of Effect
The increase in serum uric acid is dose-dependent:
- Standard doses (≥50 mg/day HCTZ or ≥25 mg/day chlorthalidone): Expect an average increase of approximately 90 μmol/L 3
- Low doses (≤25 mg/day HCTZ or ≤12.5 mg/day chlorthalidone): Expect approximately half this increase 3
Recent research confirms that 24.5% of thiazide users develop hyperuricemia compared to 15.3% of non-users, with significantly higher mean serum uric acid levels (5.9 vs 5.3 mg/dL, p=0.02) 4. The risk increases with duration of use—patients taking thiazides for more than 4 years show 46% prevalence of hyperuricemia 4.
Clinical Management in Gout Patients
When gout occurs in a patient receiving thiazide diuretics, substitute the diuretic if possible 5. This is a Grade C recommendation from the 2016 EULAR guidelines with strong consensus (level of agreement 8.2±0.9) 5.
Alternative Antihypertensive Options
For patients requiring continued blood pressure control:
- For hypertension: Consider losartan (has uricosuric effects) or calcium channel blockers 5, 6
- For hyperlipidemia: Consider fenofibrate (has modest uricosuric effects) 5, 6
Losartan specifically decreases serum uric acid and increases urinary uric acid excretion without increasing the risk of acute urate nephropathy 7. When combined with amlodipine (versus HCTZ), losartan/amlodipine reduced serum uric acid from 6.5 to 4.6 mg/dL, while losartan/HCTZ showed no significant change 8.
Important Caveats
Gout Development is Uncommon at Lower Doses
While uric acid levels increase, actual gout occurrence is uncommon with dosages ≤50 mg/day of HCTZ or ≤25 mg of chlorthalidone 1. The JNC 7 guidelines note this distinction—biochemical hyperuricemia does not always translate to clinical gout.
Monitoring Recommendations
Serum uric acid levels should be monitored after starting thiazide diuretics 3. This is particularly important in:
- Patients with prior gout history
- Those on higher doses
- Long-term users (risk increases with duration) 4
Gender Differences
The hyperuricemic effect appears more pronounced in men than women 4. Estrogen-progestin therapy can actually reverse the unfavorable effect of HCTZ on uric acid levels in postmenopausal women 9.
Bottom Line
HCTZ reliably increases serum uric acid through decreased renal excretion. In patients with established gout, thiazide diuretics should be discontinued if possible and replaced with alternatives like losartan or calcium channel blockers that do not raise (or may even lower) uric acid levels 5, 6. This approach addresses both blood pressure control and reduces the metabolic burden contributing to gout flares.